Clinical trial
Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device That Allows the Measurement of Regional Cerebral Blood Flow (rCBF), Intracranial Pressure (ICP), Brain Temperature Monitoring and Ventricular Cerebrospinal Fluid (CSF) Drainage in Brain-injured Patients
NCT03249220 is registered in ClinicalTrials.gov with Carag AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device That Allows the Measurement of Regional Cerebral Blood Flow (rCBF), Intracranial Pressure (ICP), Brain Temperature Monitoring and Ventricular Cerebrospinal Fluid (CSF) Drainage in Brain-injured Patients
- Lead sponsor
- Carag AG
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 1, 2020
- Completion date
- September 30, 2027
- Enrollment
- 1 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.